Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL2240490 | 0.90 | CA2 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL1750663 | 0.90 | CA2 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL30662099 | 0.89 | ALDH1A1 (0.47) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28271598 | 0.87 | CA2 (0.43) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL9460589 | 0.86 | ALDH1A1 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28243370 | 0.86 | ALDH1A1 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL27964313 | 0.86 | ALDH1A1 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL2290380 | 0.86 | ALDH1A1 (0.45) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL39465 | 0.86 | ALDH1A1 (0.50) | CA2CA1ALDH1A1L3MBTL1CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL295 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366559-A1 | METHODS OF TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | SUMITOMO PHARMA AMERICA, INC. (US) | 2024-11-07 | — | — | US | claimed |
| EP-4736951-A2 | (S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING, PREVENTING AND/OR MANAGING A NEUROLOGICAL AND/OR PSYCHIATRIC DISORDER | Sumitomo Pharma America, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025009867-A1 | METHOD FOR MANUFACTURING CONDUCTIVE ACRYLIC FIBER AND CONDUCTIVE ACRYLIC FIBER MANUFACTURED THEREBY | 다나눔패션 주식회사 | 2025-01-09 | — | — | WO | disclosed |
| US-20240366559-A1 | METHODS OF TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | SUMITOMO PHARMA AMERICA, INC. (US) | 2024-11-07 | — | — | US | disclosed |
| WO-2023204304-A1 | METHOD FOR PRODUCING 7H-PYRROLO[2,3-D]PYRIMIDINE-4-AMINE DERIVATIVE | 大鵬薬品工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| US-11738002-B2 | Methods of treating neurological and psychiatric disorders | SUNOVION PHARMACEUTICALS INC. (US) | 2023-08-29 | — | — | US | disclosed |
| EP-4135690-A1 | (S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Sunovion Pharmaceuticals Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| CN-115407606-A | Composition for photoresist underlayer | 罗门哈斯电子材料韩国有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-113126432-A | Coating composition for photoresist underlayer | 罗门哈斯电子材料韩国有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-9289381-B2 | Stabilization and storage of biological pharmaceutical compositions | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2016-03-22 | — | — | US | disclosed |
| US-20120230944-A1 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-09-13 | — | — | US | disclosed |
| WO-2011069037-A2 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2011-06-09 | — | — | WO | disclosed |
| US-20070048660-A1 | Resist composition, method for forming resist pattern, semiconductor device and method for manufacturing thereof | FUJITSU LIMITED (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-1757983-A1 | Resist composition, method for forming resist pattern, semiconductor device and method for manufacturing thereof | Fujitsu Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| EP-0170288-A2 | Additive for improving weathering resistance and decreasing viscosity of high solids coatings | UNION CARBIDE CORPORATION (US) | 1986-02-05 | — | — | EP | disclosed |
| US-4556693-A | COPOLYMER OF HYDROXY (METH) ACRYLATE AND POLYCAPROLACTONE HEXOL | UNION CARBIDE CORPORATION (US) | 1985-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11738002-B2 | Methods of treating neurological and psychiatric disorders | GRIN2A, SLC6A3, GRIN2C | CA2 2748/4885CA1 2244/4885ALDH1A1 1649/4885 |
| US-20240366559-A1 | METHODS OF TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | GRIN2A, SLC6A3, GRIN2C | CA2 2748/4885CA1 2244/4885ALDH1A1 1649/4885 |
| US-20120230944-A1 | STABILIZATION AND STORAGE OF BIOLOGICAL PHARMACEUTICAL COMPOSITIONS | IL2, IL2RA, IL36G | CA2 1853/4885CA1 4068/4885ALDH1A1 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.